AR088035A1 - Composiciones que comprenden maltotriosa y metodos para el uso de las mismas para inhibir el daño provocado por los procesos de deshidratacion - Google Patents

Composiciones que comprenden maltotriosa y metodos para el uso de las mismas para inhibir el daño provocado por los procesos de deshidratacion

Info

Publication number
AR088035A1
AR088035A1 ARP120103542A ARP120103542A AR088035A1 AR 088035 A1 AR088035 A1 AR 088035A1 AR P120103542 A ARP120103542 A AR P120103542A AR P120103542 A ARP120103542 A AR P120103542A AR 088035 A1 AR088035 A1 AR 088035A1
Authority
AR
Argentina
Prior art keywords
compositions
methods
dehydration processes
damage caused
maltotrious
Prior art date
Application number
ARP120103542A
Other languages
English (en)
Inventor
Ao Zihua
M Gonzalez Juan
J Taylor Bradley
Original Assignee
Mjn Us Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46846027&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR088035(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc
Publication of AR088035A1 publication Critical patent/AR088035A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A23L29/35Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/20Removal of unwanted matter, e.g. deodorisation or detoxification
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745Bifidobacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04Preserving or maintaining viable microorganisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pediatric Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Composiciones que comprenden maltotriosa. En ciertas formas de realización, las composiciones comprenden maltotriosa y por lo menos un componente, tal como un microorganismo vivo, cuya función es sometida a deterioro por los procesos de deshidratación. Métodos para la inhibición del daño provocado por deshidratación. En algunas formas particulares de realización, el método incluye la preparación de una composición que comprende maltotriosa y por lo menos un componente cuya función es sometida a deterioro por los procesos de deshidratación y la extracción de agua de la composición mediante uno o más procesos de deshidratación.
ARP120103542A 2011-10-11 2012-09-26 Composiciones que comprenden maltotriosa y metodos para el uso de las mismas para inhibir el daño provocado por los procesos de deshidratacion AR088035A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13/270,607 US20130089638A1 (en) 2011-10-11 2011-10-11 Compositions Comprising Maltotriose And Methods Of Using Same To Inhibit Damage Caused By Dehydration Processes

Publications (1)

Publication Number Publication Date
AR088035A1 true AR088035A1 (es) 2014-05-07

Family

ID=46846027

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120103542A AR088035A1 (es) 2011-10-11 2012-09-26 Composiciones que comprenden maltotriosa y metodos para el uso de las mismas para inhibir el daño provocado por los procesos de deshidratacion

Country Status (15)

Country Link
US (1) US20130089638A1 (es)
EP (1) EP2765872A1 (es)
CN (2) CN107647394A (es)
AR (1) AR088035A1 (es)
BR (1) BR112014008498A2 (es)
CA (1) CA2852109A1 (es)
CO (1) CO6940418A2 (es)
EC (1) ECSP14000460A (es)
HK (2) HK1199797A1 (es)
MX (1) MX2014004060A (es)
PE (1) PE20142080A1 (es)
RU (1) RU2014110708A (es)
SG (1) SG11201400696XA (es)
TW (2) TW201325460A (es)
WO (1) WO2013055463A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3369805B1 (en) 2015-10-30 2020-08-26 Kabushiki Kaisha Yakult Honsha Method for producing dried microbial cells
EP3524051A1 (en) * 2018-02-12 2019-08-14 DuPont Nutrition Biosciences ApS Matricial microencapsulation compositions

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3792183A (en) * 1971-08-10 1974-02-12 Nabisco Inc Cereal coating composition and process
JPS60258125A (ja) * 1984-06-06 1985-12-20 Hayashibara Biochem Lab Inc 蛋白性生理活性物質を含有する水溶性乾燥物
US4814267A (en) * 1984-09-18 1989-03-21 Michigan Biotechnology Institute Method for preparing high conversion syrups and other sweeteners
DE68912719T2 (de) * 1988-11-10 1994-07-21 Takeda Chemical Industries Ltd Saure Urease-Zubereitungen für alkoholische Getränke.
US5145697A (en) * 1989-04-26 1992-09-08 Mpy Foods, Inc. Instant yogurt composition and process
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
AU661297B2 (en) 1991-01-24 1995-07-20 Martek Corporation Microbial oil mixtures and uses thereof
AU659645B2 (en) * 1991-06-26 1995-05-25 Inhale Therapeutic Systems Storage of materials
US5374567A (en) 1993-05-20 1994-12-20 The United States Of America As Represented By The Secretary Of The Navy Operational amplifier using bipolar junction transistors in silicon-on-sapphire
DK0729383T3 (da) 1993-11-17 2000-02-07 Niro Holding As Fremgangsmåde og forstøvningstørringsapparat til fremstilling af et agglomereret pulver
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
ATE298363T1 (de) * 1996-07-09 2005-07-15 Nestle Sa Verfahren zur sprühtrocknung
US6223455B1 (en) 1999-05-03 2001-05-01 Acusphere, Inc. Spray drying apparatus and methods of use
US6463675B1 (en) 1999-09-29 2002-10-15 Niro A/S Process and a plant for spray drying
US6322994B1 (en) * 1999-11-04 2001-11-27 Genetix Limited Method of freeze-drying organisms
EP1260227A1 (en) * 2001-05-23 2002-11-27 Societe Des Produits Nestle S.A. Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
FR2829147B1 (fr) * 2001-08-30 2003-12-12 Agronomique Inst Nat Rech Procede de preparation d'une composition lyophilisee contenant des bacteries lactiques a viabilite et activite bacteriennes ameliorees lors d'un stockage a temperature ambiante et composition obtenue
US6838097B1 (en) * 2001-12-14 2005-01-04 Stephen Tsengas Pet food product
NZ537706A (en) * 2002-06-28 2008-03-28 Puleva Biotech Sa Probiotic microbial strains, comprising non-pathogenic strains which are capable of surviving in and being transferred to breast milk and/or amniotic fluid after oral intake in healthy individuals without colonizing other internal organs except mucousas
WO2006029467A1 (en) * 2004-09-16 2006-03-23 Btf Pty Ltd Rapid freeze drying process
EP1656930A1 (en) 2004-11-10 2006-05-17 Basilea Pharmaceutica AG Stabilized freeze-dried formulation for cephalosporin derivatives
CN101080176B (zh) * 2004-12-21 2011-12-07 弗门尼舍有限公司 包封的多不饱和脂肪酸
KR101229855B1 (ko) * 2005-03-31 2013-02-05 미쓰비시 가가꾸 가부시키가이샤 열화 방지제
US7572474B2 (en) 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
EP1967196A4 (en) * 2005-11-18 2009-10-14 Idemitsu Kosan Co CONTROL AGENT OF A TOXIC BACTERIUM CONTAINING BACILLUS THURINGIENSIS
JP4889317B2 (ja) * 2006-02-17 2012-03-07 オリエンタル酵母工業株式会社 マルトトリオース高含有組成物及びその製造方法
EP1903291A1 (en) 2006-09-19 2008-03-26 Ima-Telstar S.L. Method and system for controlling a freeze drying process
NZ585619A (en) * 2007-12-20 2012-06-29 Abbott Lab Nutritional powder composition comprising carbohydrate, lipid, hydrolysed whey and intact protein
WO2009108689A1 (en) * 2008-02-25 2009-09-03 Novavax, Inc. Sugar glassified virus like particles (vlps)
CN101313715A (zh) * 2008-07-09 2008-12-03 内蒙古蒙牛乳业(集团)股份有限公司 一种添加维生素适用于12到36个月的婴儿液态乳
US20110070334A1 (en) * 2009-09-20 2011-03-24 Nagendra Rangavajla Probiotic Stabilization
RU2573324C2 (ru) * 2010-08-13 2016-01-20 Эдванст Байоньютришн Корпорейшн Стабилизирующая композиция для сухого хранения биологических материалов (варианты)

Also Published As

Publication number Publication date
HK1199797A1 (en) 2015-07-24
SG11201400696XA (en) 2014-08-28
PE20142080A1 (es) 2014-12-24
CN107647394A (zh) 2018-02-02
US20130089638A1 (en) 2013-04-11
RU2014110708A (ru) 2015-11-20
MX2014004060A (es) 2014-07-09
CO6940418A2 (es) 2014-05-09
BR112014008498A2 (pt) 2017-04-11
CA2852109A1 (en) 2013-04-18
ECSP14000460A (es) 2015-06-30
TW201822640A (zh) 2018-07-01
WO2013055463A1 (en) 2013-04-18
TW201325460A (zh) 2013-07-01
EP2765872A1 (en) 2014-08-20
CN103929979A (zh) 2014-07-16
HK1250315A1 (zh) 2018-12-14

Similar Documents

Publication Publication Date Title
CL2016000882A1 (es) Composiciones de arni contra el componente c5 del complemento y métodos para su uso (divisional de sol. n°2710-15).
ECSP14004812A (es) Triazolopiridinas sustituidas
ECSP14016162A (es) Combinaciones de compuestos activos
CL2014000630A1 (es) Una composicion que comprende 1) un compuesto derivado de nucleosido denominado como compuesto 10 y 2) un compuesto derivado de acido 5-tiofeno-2-carboxilico denominado como compuesto 5 o un compuesto derivado del ester metilico del acido carbamico denominado como compuesto 6; y su uso para el tratamiento profilactico o terapeutico de una infeccion por vhc.
DOP2014000204A (es) Compuestos de heterociclilo como inhibidores de mek
GT201400043A (es) Imidazopiridazinas sustituidas con amino
ECSP13013074A (es) Nuevos derivados de piridina
SV2017005466A (es) Pirazolpiridinaminas como inhibidores de mknk1 y mknk2
CR20150250A (es) Nuevos derivados de piridina
CR20150447A (es) Nuevos derivados de pirazol
DOP2016000253A (es) Nuevos compuestos
ECSP13013011A (es) Triazolopiridinas
ECSP12012270A (es) Compuestos de pirazol como inhibidores del receptor sigma
CR20120357A (es) Composición que comprende un pesticida y un alcoxilato de 2-propilheptilamina
ECSP12012338A (es) Triazolopiridinas sustituidas
NI201400042A (es) 2 - tiopirimidinonas
DOP2016000118A (es) Tienopirimidinas como inhibidores mknk1 y mknk2
CO6731092A2 (es) Nueva forma de administración de inhibidor de encefalinasa
CL2013002034A1 (es) Composicion que comprende al menos un analogo de prostaciclina; su uso para tratar una enfermedad de la medula osea; y metodo para mejorar el injerto de celulas madre hematopoyeticas.
DOP2016000268A (es) Compuestos de azol amido–sustituidos como inhibidores de tnks1 y/o tnks2
PE20141584A1 (es) Uso de un inhibidor de aromatasa para el tratamiento del hipogonadismo y enfermedades relacionadas
CL2013002903A1 (es) Composicion que comprende azadiractina; metodo para el tratamiento anti-macroincrustacion de al menos un polimeros; y su uso.
CL2016002532A1 (es) Compuestos derivados de diheterociclo enlazado a cicloalquilo con actividad inhibidora de gls1 uso en el tratamiento de crecimiento celular anormal, tal como cáncer composición farmacéutica que los contiene
DOP2016000251A (es) Inhibidores de las vías de señalización de wnt
AR088035A1 (es) Composiciones que comprenden maltotriosa y metodos para el uso de las mismas para inhibir el daño provocado por los procesos de deshidratacion

Legal Events

Date Code Title Description
FB Suspension of granting procedure